Sign in
4

Changes in Ownership

Inmune Bio Inc. Filed Acc 0001213900-22-014509

Chief Scientific Officer acquired 23,590 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lowdell Mark William · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-22 Grant or award : show line 1 in the form +23,590 $8.43 $198,864 1,496,383 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-21 Grant or award : show line 2 in the form Option (right to buy) +104,000 104,000 D
Loading xslF345X03/ownership.xml…